Rare Diseases and Orphan Drugs
This session highlights the challenges and innovations in diagnosing and treating rare diseases, as well as the development of orphan drugs. Topics will include patient advocacy, policy frameworks, and the integration of genomic technologies.
Sub tracks:
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
